These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10188987)
41. Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aorta. Joly GA; Ayres M; Kilbourn RG FEBS Lett; 1997 Feb; 403(1):40-4. PubMed ID: 9038357 [TBL] [Abstract][Full Text] [Related]
42. Endotoxin-induced vascular hyporesponsiveness in rat aorta: in vitro effect of aminoguanidine. Ulker S; Cinar MG; Can C; Evinç A; Koşay S Pharmacol Res; 2001 Jul; 44(1):22-7. PubMed ID: 11428906 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430 [TBL] [Abstract][Full Text] [Related]
44. Nitric oxide dependent and independent effects of in vitro incubation or endotoxin on vascular reactivity in rat aorta. Wylam ME; Metkus AP; Umans JG Life Sci; 2001 Jun; 69(4):455-67. PubMed ID: 11459436 [TBL] [Abstract][Full Text] [Related]
45. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages. Kang YJ; Koo EB; Lee YS; Yun-Choi HS; Chang KC Br J Pharmacol; 1999 Sep; 128(2):357-64. PubMed ID: 10510445 [TBL] [Abstract][Full Text] [Related]
46. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. Kim ND; Kim EM; Kang KW; Cho MK; Choi SY; Kim SG Br J Pharmacol; 2003 Oct; 140(4):661-70. PubMed ID: 14534150 [TBL] [Abstract][Full Text] [Related]
47. Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat. Zhao Y; Vanhoutte PM; Leung SW J Pharmacol Exp Ther; 2013 Jan; 344(1):15-22. PubMed ID: 23008504 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of endotoxin-induced vascular hyporeactivity by 4-amino-tetrahydrobiopterin. Gibraeil HD; Dittrich P; Saleh S; Mayer B Br J Pharmacol; 2000 Dec; 131(8):1757-65. PubMed ID: 11139456 [TBL] [Abstract][Full Text] [Related]
50. Response of alveolar macrophages from inducible nitric oxide synthase knockout or wild-type mice to an in vitro lipopolysaccharide or silica exposure. Zeidler PC; Roberts JR; Castranova V; Chen F; Butterworth L; Andrew ME; Robinson VA; Porter DW J Toxicol Environ Health A; 2003 Jun; 66(11):995-1013. PubMed ID: 12775513 [TBL] [Abstract][Full Text] [Related]
51. Adventitia as a source of inducible nitric oxide synthase in the rat aorta. Zhang H; Du Y; Cohen RA; Chobanian AV; Brecher P Am J Hypertens; 1999 May; 12(5):467-75. PubMed ID: 10342784 [TBL] [Abstract][Full Text] [Related]
52. Thaliporphine selectively inhibits expression of the inducible, but not the constitutive, nitric oxide synthase. Yu SM Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):289-94. PubMed ID: 7524482 [TBL] [Abstract][Full Text] [Related]
53. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406 [TBL] [Abstract][Full Text] [Related]
54. An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient mice. Nangle MR; Cotter MA; Cameron NE Pflugers Arch; 2004 May; 448(2):139-45. PubMed ID: 14722775 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of inducible nitric oxide synthase expression and stimulation of the endothelial formation of nitric oxide most likely accounts for the protective effect of 2-(allylthio)pyrazine in a murine model of endotoxemia. Kim ND; Kang KW; Kim SG; Schini-Kerth VB Biochem Biophys Res Commun; 1997 Oct; 239(1):310-5. PubMed ID: 9345316 [TBL] [Abstract][Full Text] [Related]
56. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Miles PR; Bowman L; Rao KM; Baatz JE; Huffman L Am J Physiol; 1999 Jan; 276(1):L186-96. PubMed ID: 9887071 [TBL] [Abstract][Full Text] [Related]
57. Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat. Li Y; Cui X; Xu W; Ohanjanian L; Sampath-Kumar H; Suffredini D; Moayeri M; Leppla S; Fitz Y; Eichacker PQ Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H781-93. PubMed ID: 27448553 [TBL] [Abstract][Full Text] [Related]
58. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Ruetten H; Southan GJ; Abate A; Thiemermann C Br J Pharmacol; 1996 May; 118(2):261-70. PubMed ID: 8735625 [TBL] [Abstract][Full Text] [Related]
59. Induction of nitric oxide production by bovine alveolar macrophages in response to Pasteurella haemolytica A1. Yoo HS; Rutherford MS; Maheswaran SK; Srinand S; Ames TR Microb Pathog; 1996 Jun; 20(6):361-75. PubMed ID: 8831831 [TBL] [Abstract][Full Text] [Related]
60. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Zingarelli B; Haskó G; Salzman AL; Szabó C Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]